收藏切换
Research progress in traditional Chinese medicine targeting NLRP3 inflammasome for the treatment of osteoporosis
收藏切换
PDF
Liang-tong ZHANG1, Yuan CHENG1, Xing-wen XIE1, 2, Ren-wei ZHANG1, You-liang ZHANG1, Xin CHEN1, 2
Chinese Journal of Clinical Pharmacology | 2025, 41(17) : 2539 - 2543
Less
收藏切换
Chinese Journal of Clinical Pharmacology | 2025, 41(17): 2539-2543
Review
Research progress in traditional Chinese medicine targeting NLRP3 inflammasome for the treatment of osteoporosis
Full
Liang-tong ZHANG1, Yuan CHENG1, Xing-wen XIE1, 2, Ren-wei ZHANG1, You-liang ZHANG1, Xin CHEN1, 2
Affiliations
  • 1.Clinical School of Chinese Medicine, Gansu University of Chinese Medicine, Lanzhou 730000, Gansu Province, China
  • 2.Department of Geriatric Orthopedics, Affiliated Hospital of Gansu University of Traditional Chinese Medicine, Lanzhou 730000, Gansu Province, China
Published: 2025-09-17 doi: 10.13699/j.cnki.1001-6821.2025.17.024
Outline
收藏切换

Osteoporosis (OP) is a common systemic chronic metabolic bone disease that primarily affects individuals over the age of 50. It is highly prone to causing complications such as fractures, which severely impair patients’ health and quality of life. The nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome is composed of the NLRP3 receptor, apoptosis-associated speck-like protein containing a CARD (ASC), and pro-caspase-1. In the chronic inflammatory microenvironment induced by aging or estrogen deficiency, this inflammasome is activated. It mediates inflammatory responses and induces pyroptosis by regulating the maturation and secretion of caspase-1-dependent proinflammatory cytokines, namely interleukin-1β (IL-1β) and interleukin-18 (IL-18). This process not only accelerates bone resorption but also inhibits bone formation, ultimately increasing the risk of OP. Traditional Chinese medicine (TCM) can exert therapeutic effects on OP by targeting the NLRP3 inflammasome. This article comprehensively reviews the structure and activation process of the NLRP3 inflammasome, as well as the complex mechanisms through which TCM treats OP by targeting the NLRP3 inflammasome. The aim is to provide new insights for the targeted therapy of OP and serve as a reference for identifying ideal therapeutic targets for OP.

traditional Chinese medicine  /  osteoporosis  /  nucleotide-binding oligomerization domain-like receptor protein 3  /  caspase-1  /  interleukin-1β  /  interleukin-18
Liang-tong ZHANG, Yuan CHENG, Xing-wen XIE, Ren-wei ZHANG, You-liang ZHANG, Xin CHEN. Research progress in traditional Chinese medicine targeting NLRP3 inflammasome for the treatment of osteoporosis[J]. Chinese Journal of Clinical Pharmacology, 2025 , 41 (17) : 2539 -2543 . DOI: 10.13699/j.cnki.1001-6821.2025.17.024
Year 2025 volume 41 Issue 17
PDF
151
43
Cite this Article
BibTeX
Article Info
doi: 10.13699/j.cnki.1001-6821.2025.17.024
  • Receive Date:2024-09-09
  • Online Date:2026-08-05
  • Published:2025-09-17
Article Data
Affiliations
History
  • Received:2024-09-09
Funding
Affiliations
    1.Clinical School of Chinese Medicine, Gansu University of Chinese Medicine, Lanzhou 730000, Gansu Province, China
    2.Department of Geriatric Orthopedics, Affiliated Hospital of Gansu University of Traditional Chinese Medicine, Lanzhou 730000, Gansu Province, China
References
Share
https://castjournals.cast.org.cn/joweb/zglcylxzz/EN/10.13699/j.cnki.1001-6821.2025.17.024
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT